The Pharma Data

FEBRUARY 25, 2021

and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Lilly will commercialize the pen platform, which will include the new app and Lilly’s connected insulin pen solutions.

Insulin 40

Insulin Medicine Hormones Development 40

pharmaphorum

NOVEMBER 21, 2022

The company argues that the cost is justified as Tzield (teplizumab) is the first drug that can delay the onset of type 1 diabetes, fending off the time when they become highly reliant on insulins and at risk of the serious complications that can accompany advanced T1D. It also has an option on global marketing rights to the drug.

Drugs 116

Drugs Insulin FDA Approval Sales 116

XTalks

OCTOBER 22, 2021

In July 2021, the agency approved the first interchangeable biosimilar product, Semglee (insulin glargine-yfgn) for the treatment of diabetes. Semglee is both biosimilar to, and interchangeable with, Lantus (insulin glargine).

FDA Approval 98

FDA Approval Production Insulin Antibody 98

pharmaphorum

MAY 21, 2021

Based in Cambridge, Arecor has proprietary formulation technology and plans to enter development partnerships and licence out drugs to big pharma companies, looking for milestone payments and royalties as they progress through the development process and on commercialisation.

Insulin 52

Insulin Drugs Production Marketing 52

pharmaphorum

JUNE 18, 2021

UK company MIOTIFY has developed a web-based software platform that product teams can use to configure medical algorithms quickly, create code packages to harness them and generate supporting documentation – all in a format that is designed to meet regulatory requirements for software as a medical device (SaMD). . The next steps?

Production 98

Production Regulation Manufacturing Packaging 98

pharmaphorum

MARCH 7, 2022

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. . ” About the author .

Vaccination 98

Vaccination Vaccine Manufacturing Production 98

Pharmaceutical Technology

AUGUST 15, 2022

The country has a long history of leadership and innovation in this field, from the discovery of stem cells and insulin to the invention of the world’s first pacemaker and much more. Over the past five years, the life sciences sector produced a total of 83 commercialised or licensed products and services.

Life Science 130

Life Science Research Manufacturing Insulin 130

pharmaphorum

JUNE 14, 2021

This can lead to metabolic abnormalities including insulin resistance, diabetes, and elevated levels of blood lipids (such as high cholesterol). Eventually it was bought by Amryt who, keen to get the drug licensed, resubmitted it to NICE in 2020. The earlier HTAs, researchers and pharma companies can start that engagement the better.

Drugs 105

Drugs Pharma Companies Licensing Licensing 105

Roots Analysis

AUGUST 1, 2024

Currently, more than 10 GLP-1 receptor agonists are commercially available, while various molecules are under development for various disease indications. Within clinical stage of development, majority (43) drug candidates are in Phase II of development followed by Phase I (34). per package in the US.

Marketing 52

Marketing Insulin Drugs Development 52

BioSpace

NOVEMBER 17, 2022

Editas Medicine is pausing its ocular gene therapy program after demonstrating a favorable safety profile and seeking a potential partner to develop EDIT-101, the company announced Thursday.

Gene Therapy 42

Gene Therapy Gene Gene Editing Medicine 42

FDA Law Blog

NOVEMBER 16, 2021

139001 lays out a process by which the Secretary would: Identify “negotiation-eligible drugs” from among qualifying single-source drugs that are among the top 50 with the highest Part D spending, the top 50 with the highest Part B spending, and insulins. Here are the important points from the MedPac summary: Sec.

Generic Drugs 52

Generic Drugs Manufacturing Drugs Licensing 52

Roots Analysis

FEBRUARY 22, 2022

Further, in order to improve the quality of life in these patients, companies have developed novel devices capable of delivering a variety of formulations of different drugs / therapies, in an efficient and relatively simple manner. Rising Need of Autoinjectors – Roots Analysis. Rising Need of Autoinjectors – Roots Analysis.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

The Pharma Data

JANUARY 7, 2021

In addition, icosabutate lowered triglyceride levels, improved insulin resistance and lowered hsCRP by an impressive 50%, biomarker changes that improve the patient’s cardiovascular risk profile. 8, 2021 08:00 UTC. A Phase 2b study was initiated in July 2019 (ICONA) to study the efficacy of icosabutate in NASH.

Engineer 40

Engineer Insulin Development Licensing 40

The Pharma Data

DECEMBER 15, 2020

On top of this, another 8 million carry auto-antibodies, blood molecules that indicate a person’s chance of developing an autoimmune disease. Many drug makers are investing in new science and hope to develop new therapeutics that address autoimmune disease. The cause of many of the diseases is unknown. . Inflammatory Overreaction.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

XTalks

SEPTEMBER 17, 2020

While the table lists acceptable surrogate endpoints for trials of more common conditions, such as asthma, type 2 diabetes and various cancer types, the document also provides key information to developers of certain rare disease therapies. What Is a Surrogate Endpoint? Prevalence: 1 in 7,000 to 1 in 10,000.

Trials 98

Trials Gene Hormones Clinical Trials 98

XTalks

JUNE 12, 2023

These powerhouse organizations have not only distinguished themselves through their cutting-edge devices and technologies but also via their robust research and development (R&D) capabilities, unwavering commitment to quality and extensive global reach. The company reported an investment of $2.7

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

The Pharma Data

DECEMBER 27, 2020

United Therapeutics is developing Tyvaso DPI under a collaboration and license agreement with MannKind Corporation. Tyvaso DPI incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza ® (insulin human) Inhalation Powder product, approved by the FDA in 2014.

Production 52

Production Drugs Containment Bioinformatics 52

Pharma Marketing Network

OCTOBER 27, 2020

So a doctor that’s licensed stay only in the state of New York would be able to practice across the entire counties using Telemedicine. Don ( PMN): This is really interesting too and that is the one that we’ve spoken about earlier in previous conversations was the aerosolized insulin? Robin (Guest): Yup. Don ( PMN): Wow.

Insulin 52

Insulin Marketing Doctors Doctor 52

Pharma Marketing Network

OCTOBER 27, 2020

So a doctor that’s licensed stay only in the state of New York would be able to practice across the entire counties using Telemedicine. Don ( PMN): This is really interesting too and that is the one that we’ve spoken about earlier in previous conversations was the aerosolized insulin? Robin (Guest): Yup. Don ( PMN): Wow.

Insulin 52

Insulin Doctors Doctor Marketing 52

XTalks

FEBRUARY 8, 2021

Last year, Biocon Biologics and Mylan announced they’d be seeking interchangeable status for their long-acting insulin product Semglee , developed to be an alternative to Sanofi’s Lantus (insulin glargine). In fact, innovator biologics and their biosimilars are approved through two different regulatory pathways.

Production 78

Production Insulin Branding Generic Drugs 78

The Pharma Data

AUGUST 17, 2021

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52

Insulin FDA Approval Doctors Doctor 52

XTalks

OCTOBER 26, 2020

Familial history is a strong predictor for type 1 diabetes (T1D), with people who have family members with the disease being 15 times more likely to develop it. According to Proventia , both campaigns focus on the need to screen patients at greater risk of developing T1D due to having one or more family members with T1D. TID affects 1.6

Insulin 98

Insulin Packaging Packaging Doctors 98

pharmaphorum

MAY 17, 2021

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. Arecor has four active licensing agreement in place with partners including Hikma and Inhibrx.

Insulin 52

Insulin Production Marketing Pharma Companies 52

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. The trial compared tirzepatide to insulin glargine in adults with type 2 diabetes and increased cardiovascular risk. Business Development/Other Developments.

Antibody 52

Antibody Sales Development Production 52

The Pharma Data

APRIL 1, 2021

“We welcome the ongoing partnership with the Canadian authorities, who supported us to make today’s great news a reality; this will make the country, which has a strong legacy in vaccines research and development, one of our key hubs in our effort to protect and improve human health across the globe.”.

Vaccination 52

Vaccination Vaccine Manufacturing Insulin 52

The Pharma Data

MAY 15, 2021

Your ‘Fat Burning Switch’ can’t be activated in the presence of insulin. The ingredients in LumaSlim are the ONLY natural compounds PROVEN to turn your ‘Fat Burning Switch’ ON, even in the presence of insulin! We developed this guide at the request of many of our customers…. And it is FREE with your LumaSlim order today!

Production 52

Production Packaging Packaging Sales 52

The Pharma Data

AUGUST 17, 2021

This new indication follows an FDA priority review of the Biologics License Application and is based on the collective results from the dMMR endometrial cancer cohort A1 and the dMMR solid-tumour (non-endometrial cancer) cohort F of the ongoing GARNET trial. [vii] JEMPERLI was discovered by AnaptysBio and licensed to TESARO, Inc.,

FDA Approval 52

FDA Approval Antibody DNA Hormones 52

XTalks

AUGUST 2, 2023

is a global pharmaceutical company, working across both developed and emerging markets. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

SEPTEMBER 1, 2020

Whilst the scientific revolution of the 17th century had spread ideas of rationalism and experimentation, and the industrial revolution had transformed the production of goods in the late 18th century, the marrying of the two concepts for the benefit of human health was a comparatively late development.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

The Pharma Data

APRIL 1, 2021

“Diabetes is a complex condition, and each specialty should be prioritizing their patients’ overall health and developing treatment plans in collaboration with other specialists without worrying of overstepping,” said Javed Butler, M.D., The findings are from a survey of 1,000 U.S. healthcare professionals (i.e.,

Nurses 52

Nurses Cardiology Medicine Insulin 52

Pharmacy Checkers

MARCH 11, 2020

The agency has created a well-thought-out roadmap for states and other non-federal entities to safely import medications directly from licensed and qualified Canadian wholesale pharmacies that charge lower prices than their U.S. counterparts.

Pharmacy 41

Pharmacy Drugs FDA Approval Licensing 41